Antibiotics – Worldwide Partnering Terms & Agreements 2014 to 2019: Deal Trends, Players & Financials

    NEXT STORY
    Turning Point Therapeutics to Host Second Quarter 2019 Conference Call
    PREV STORY
    Salarius Pharmaceuticals Enrolls First Patient in a Phase 1 Clinical Study of its Novel Inhibitor Targeting Epigenetics in Patients with Advanced Solid Tumors
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sunesis Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., July 05, 2016 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) ...

    author_avatar
    NASDAQ Market News

    Kansas University Medical Center and iSage Rx Receive Blue Cross and Blue Shield of Kansas City (Blue KC) Outcomes Grant to Study Insulin Optimization

    Insulin-Dependent Patients Will Be Enrolled in Clinical Trial Using iSage’s FDA Cleared Insulin Titration ...

    author_avatar
    NASDAQ Market News

    Cynata’s Cymerus™ MSCs Effective in Preclinical Model of Diabetic Wounds

    MELBOURNE, Australia, June 01, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine ...

    author_avatar
    NASDAQ Market News